Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6JCya-Tmprss13em1/Cya
Common Name:
Tmprss13-KO
Product ID:
S-KO-17021
Background:
C57BL/6JCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Tmprss13-KO
Strain ID
KOCMP-214531-Tmprss13-B6J-VB
Gene Name
Tmprss13
Product ID
S-KO-17021
Gene Alias
Tpmrss13
Background
C57BL/6JCya
NCBI ID
214531
Modification
Conventional knockout
Chromosome
9
Phenotype
MGI:2682935
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6JCya-Tmprss13em1/Cya mice (Catalog S-KO-17021) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000034597
NCBI RefSeq
NM_001013373
Target Region
Exon 2
Size of Effective Region
~0.4 kb
Detailed Document
Click here to download >>
Overview of Gene Research
Tmprss13, also known as mosaic serine protease large-form (MSPL), is a member of the type II transmembrane serine protease (TTSP) family. It has trypsin-like catalytic activity and is involved in multiple biological processes. It plays a role in proteolytic processing of various molecules such as prohormones and growth factor precursors, and is also implicated in the pathogenicity of many viruses and bacteria [5].

In mice with Tmprss13 gene disrupted by a β-galactosidase-neomycin fusion gene insertion, abnormal skin development was observed, leading to compromised epidermal barrier function as measured by transepidermal fluid loss rate in newborn mice. This indicates its importance in stratum corneum formation [7]. In addition, in colorectal cancer cell lines, Tmprss13 silencing increased apoptosis and impaired invasive potential, while overexpression increased tolerance to apoptosis-inducing agents, suggesting its role in cancer cell survival and drug-resistance [4]. Regarding viral infections, Tmprss13 significantly facilitates the cell entry of swine acute diarrhea syndrome coronavirus (SADS-CoV), and also enhances the cell-cell membrane fusion and cleavage of its spike protein. Both human and pig Tmprss13 have this effect, and its action at the entry step is sensitive to serine protease inhibitor Camostat [1]. Tmprss13 can also cleave the spike protein of SARS-CoV-2 and allow its pseudotyped virus entry into cells. Exogenous expression of Tmprss13 enhanced cellular uptake and replication of SARS-CoV-2, and it was shown to have different preferences for residues in the S2' cleavage motif of the SARS-CoV-2 spike compared to TMPRSS2 [2,3,6].

In conclusion, Tmprss13 is crucial for epidermal barrier formation during skin development. In disease contexts, it promotes cancer cell survival and drug-resistance in colorectal cancer. It also significantly impacts the cell entry of certain coronaviruses, including SADS-CoV and SARS-CoV-2. Studies using gene-knockout mouse models have been instrumental in revealing these functions, providing insights into potential therapeutic targets for skin-related disorders, cancer, and viral infections.

References:

1. Han, Yutong, Ma, Yanlong, Wang, Ziqiao, Ye, Rong, Zhang, Rong. . TMPRSS13 promotes the cell entry of swine acute diarrhea syndrome coronavirus. In Journal of medical virology, 96, e29712. doi:10.1002/jmv.29712. https://pubmed.ncbi.nlm.nih.gov/38808555/

2. Gatineau, Jérôme, Nidercorne, Charlotte, Dupont, Aurélie, Niedergang, Florence, Castellano, Flavia. 2022. IL4I1 binds to TMPRSS13 and competes with SARS-CoV-2 spike. In Frontiers in immunology, 13, 982839. doi:10.3389/fimmu.2022.982839. https://pubmed.ncbi.nlm.nih.gov/36131918/

3. Kishimoto, Mai, Uemura, Kentaro, Sanaki, Takao, Sawa, Hirofumi, Sasaki, Michihito. 2021. TMPRSS11D and TMPRSS13 Activate the SARS-CoV-2 Spike Protein. In Viruses, 13, . doi:10.3390/v13030384. https://pubmed.ncbi.nlm.nih.gov/33671076/

4. Varela, Fausto A, Foust, Victoria L, Hyland, Thomas E, Todi, Sokol V, List, Karin. 2020. TMPRSS13 promotes cell survival, invasion, and resistance to drug-induced apoptosis in colorectal cancer. In Scientific reports, 10, 13896. doi:10.1038/s41598-020-70636-4. https://pubmed.ncbi.nlm.nih.gov/32807808/

5. Kido, Hiroshi, Okumura, Yuushi. 2008. MSPL/TMPRSS13. In Frontiers in bioscience : a journal and virtual library, 13, 754-8. doi:. https://pubmed.ncbi.nlm.nih.gov/17981585/

6. Stevaert, Annelies, Van Berwaer, Ria, Mestdagh, Cato, Laporte, Manon, Naesens, Lieve. 2022. Impact of SARS-CoV-2 Spike Mutations on Its Activation by TMPRSS2 and the Alternative TMPRSS13 Protease. In mBio, 13, e0137622. doi:10.1128/mbio.01376-22. https://pubmed.ncbi.nlm.nih.gov/35913162/

7. Madsen, Daniel H, Szabo, Roman, Molinolo, Alfredo A, Bugge, Thomas H. . TMPRSS13 deficiency impairs stratum corneum formation and epidermal barrier acquisition. In The Biochemical journal, 461, 487-95. doi:10.1042/BJ20140337. https://pubmed.ncbi.nlm.nih.gov/24832573/

Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest